Rafael Amado - Insider Trading & Ownership
-
Entity
-
Individual
-
Location
-
210 East Grand Ave, South San Francisco, California
-
Summary
-
The estimated net worth of Rafael Amado is at least $2.59 M dollars as of June 18, 2024. Rafael Amado is the EVP of R&D of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $1.72 M. Rafael Amado is the President, Head of Global Oncology Research and Development of Zai Lab Ltd and owns shares of Zai Lab Ltd (ZLAB) stock worth about $630 K. Rafael Amado is the Director of Poseida Therapeutics, Inc. and owns shares of Poseida Therapeutics, Inc. (PSTX) stock worth about $243 K.